col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


44 Results       Page 1

 [1] 
Elsevier: Schizophrenia Research
  original article Date Title Authors   All Authors
1 [GO] 2022―Mar―04 COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey Carlos Gustavo Costardi, Fernando Malinowski, Lais Fonseca, Luciene Redondo, Cristiano Noto, Ary Gadelha
2 [GO] 2022―Feb―26 Negative schizotypy attenuates the effect of momentary stress on social dysfunction related to COVID-19 social distancing Michael D. Masucci, Victoria Martin, Thanh P. Le, Alex S. Cohen
3 [GO] 2022―Feb―17 Adaptive and maladaptive consequences of increased social media and internet use during the COVID-19 pandemic in schizophrenia Luyu Zhang, Gregory P. Strauss
4 [GO] 2022―Feb―01 Pandemic paranoia, general paranoia, and their relationships with worry and beliefs about self/others - A multi-site latent class analysis Suzanne Ho-wai So, Chen Zhu, Tania M. Lincoln, Brandon A. Gaudiano, Jessica L. Kingston, Lyn Ellett, Eric M.J. Morris
5 [GO] 2022―Jan―24 Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? Cintia R. Prokopez, Romina Farinola, Miguel Vallejos, Lorena S. Lopredo, Luciano E. Sfriso, Luciana C. Chiapella, et al. (+4)
6 [GO] 2022―Jan―24 First episode psychosis following receipt of first dose of COVID-19 vaccine: A case report Sandeep Grover, Seema Rani, Komal Kohat, Sanjana Kathiravan, Garima Patel, Swapnajeet Sahoo, et al. (+3)
7 [GO] 2022―Jan―10 Clozapine toxicity and coronavirus disease 2019: A case report Maria Sagué-Vilavella, Hugo López-Pelayo, Néstor Arbelo, Mercè Cámara, Susana Gomes, Santiago Madero, et al. (+2)
8 [GO] 2022―Jan―05 Correlates of Psychotic Like Experiences (PLEs) During Pandemic: An Online Study Investigating a Possible Link Between the SARS-CoV-2 Infection and PLEs Among Adolescents Helin Yilmaz Kafali, Serkan Turan, Serap Akpınar, Müge Mutlu, Aslınur Özkaya Parlakay, Esra Çöp, Timothea Toulopoulou
9 [GO] 2021―Dec―22 An overall protective effect of antipsychotic drugs against COVID-19 seems implausible Ángel Ruiz de Pellón-Santamaría, Cristina Sarasqueta-Eizaguirre, Francisco Javier Basterrechea-Peña
10 [GO] 2021―Sep―16 Psychotic behaviors during COVID-19: Should conspiracist ideation be included within the continuum model of psychosis? Álex Escolà-Gascón, Abigail C. Wright
11 [GO] 2021―Sep―14 COVID-19 dimensions and psychotic experiences among US college students: Findings from the Healthy Mind Study 2020 Hans Oh, Jessica Goehring, Ravi Rajkumar, Megan Besecker, Sasha Zhou, Jordan E. DeVylder
12 [GO] 2021―Sep―01 H1N109 pandemic research in people with schizophrenia providing insights into COVID-19 clinical care Paul A. Maguire, Rebecca E. Reay, Jeffrey C.L. Looi
13 [GO] 2021―Sep―01 Mediating role of metacognitive beliefs and cognitive-attentional syndrome in the relationship between persecutory and coronavirus conspiracy beliefs in a community sample Joachim Kowalski, Łukasz Gawęda
14 [GO] 2021―Sep―01 Changes of psychotic-like experiences and their association with anxiety/depression among young adolescents before COVID-19 and after the lockdown in China Zhipeng Wu, Zhening Liu, Zhulin Zou, Feiwen Wang, Mengran Zhu, Wen Zhang, et al. (+3)
15 [GO] 2021―Aug―07 Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India Sandeep Grover, Sanjana Kathiravan, Aarzoo Suman, Chandrima Naskar, Aseem Mehra, Swapnajeet Sahoo, Subho Chakrabarti
16 [GO] 2021―Jul―30 Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis Kelsey I. Macdonald, Michael J. Spilka, Lisa A. Bartolomeo, Ian M. Raugh, Alysia M. Berglund, Gregory P. Strauss
17 [GO] 2021―Jul―30 Can antipsychotic use protect from COVID-19? Luiz Dratcu, Xavier Boland
18 [GO] 2021―Jul―22 Starting clozapine in patients with schizophrenia during the ongoing pandemic Sandeep Grover, Chandrima Naskar, Swapnajeet Sahoo, Aseem Mehra, Subho Chakrabarti
19 [GO] 2021―Jul―14 The immediate impact of the COVID-19 pandemic on attenuated positive symptoms and functioning in individuals at clinical high risk for psychosis: A pilot study Ricardo E. Carrión, Andrea M. Auther, Danielle McLaughlin, Barbara A. Cornblatt
20 [GO] 2021―Jul―08 The role of antipsychotics against COVID-19: A topic for debate M. Canal-Rivero, R. Catalán-Barragán, A. Rubio-García, N. Garrido-Torres, B. Crespo-Facorro, M. Ruiz-Veguilla, et al. (+4)
21 [GO] 2021―Jul―02 Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions Brian O'Donoghue, Emily Castagnini, Alison Langstone, Nathan Mifsud, Andrew Thompson, Eoin Killackey, Patrick McGorry
22 [GO] 2021―Jun―26 Letter on: “Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population” Ahmad Amjed Toubasi
23 [GO] 2021―Jun―23 An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses Cintia R. Prokopez, Miguel Vallejos, Lorena S. Lopredo, Luciano E. Sfriso, Luciana C. Chiapella, Claudio Arce, et al. (+4)
24 [GO] 2021―Jun―16 New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus Umit Haluk Yesilkaya, Meltem Sen, Nesrin Karamustafalioglu
25 [GO] 2021―Mar―14 Changes in psychotic-like experiences and related influential factors in technical secondary school and college students during COVID-19 Meng Sun, Dongfang Wang, Ling Jing, Liang Zhou
26 [GO] 2021―Feb―21 Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population M. Canal-Rivero, R. Catalán Barragán, A. Rubio García, N. Garrido Torres, B. Crespo-Facorro, M. Ruiz-Veguilla
27 [GO] 2021―Feb―21 Induced ideas of reference during social unrest and pandemic in Hong Kong Stephanie M.Y. Wong, Christy L.M. Hui, Corine S.M. Wong, Y.N. Suen, Sherry K.W. Chan, Edwin H.M. Lee, et al. (+3)
28 [GO] 2021―Jan―18 Factors associated with mask wearing among psychiatric inpatients during the COVID-19 pandemic Ha-Ran Jung, Cheol Park, Mina Kim, Min Jhon, Ju-Wan Kim, Seunghyong Ryu, et al. (+6)
29 [GO] 2020―Aug―06 The COVID pandemic and the endemic disparities in care across race for psychotic disorders Fabio Ferrarelli, Matcheri S. Keshavan
30 [GO] 2020―Jul―25 COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls? Leticia González-Blanco, Francesco Dal Santo, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Carlota Moya Lacasa, Gonzalo Paniagua, et al. (+3)
31 [GO] 2020―Jul―25 Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? B. Nobile, M. Durand, P. Courtet, P. Van de Perre, N. Nagot, J.P. Molès, E. Olié
32 [GO] 2020―Jun―15 The DOSMD challenge and the COVID-19 conundrum Ravi Philip Rajkumar
33 [GO] 2020―Jun―15 Unmask the mind! Importance of video consultations in psychiatry during COVID-19 pandemic Jagadisha Thirthalli, Narayana Manjunatha, Suresh Bada Math
34 [GO] 2020―May―28 Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic Sandeep Grover, Eepsita Mishra, Subho Chakrabarti, Aseem Mehra, Swapnajeet Sahoo
35 [GO] 2020―May―27 The impact of COVID-19 on individuals living with serious mental illness Kareem Hamada, Xiaoduo Fan
36 [GO] 2020―May―26 Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic Jessica Nichols, Jessica M. Gannon, Judith Conlogue, Deepak Sarpal, Jamie L. Montgomery, Robin Sherwood, et al. (+4)
37 [GO] 2020―May―16 The “mind” behind the “mask”: Assessing mental states and creating therapeutic alliance amidst COVID-19 Urvakhsh Meherwan Mehta, Ganesan Venkatasubramanian, Prabha S. Chandra
38 [GO] 2020―May―14 Clozapine treated patients and COVID-19: Ensuring continued care through collaboration Jonathan G. Leung, Terri S. Wittenberger, Kathryn M. Schak
39 [GO] 2020―May―13 Psychotic experiences in student population during the COVID-19 pandemic Michal Hajdúk, Daniel Dančík, Jakub Januška, Viktor Svetský, Alexandra Straková, Michal Turček, et al. (+4)
40 [GO] 2020―May―07 Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions Jessica M. Gannon, Judith Conlogue, Robin Sherwood, Jessica Nichols, Juliette R. Ballough, Noreen M. Fredrick, K.N. Roy Chengappa
41 [GO] 2020―May―06 The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research Ellie Brown, Richard Gray, Samantha Lo Monaco, Brian O'Donoghue, Barnaby Nelson, Andrew Thompson, et al. (+2)
42 [GO] 2020―Apr―27 Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge Petru Ifteni, Lorena Dima, Andreea Teodorescu
43 [GO] 2020―Apr―16 COVID-19, mobile health and serious mental illness John Torous, Matcheri Keshavan
44 [GO] 2020―Apr―04 Is schizophrenia research relevant during the COVID-19 pandemic? Henry R. Cowan
 [1] 

44 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.008 sec